International Journal of Tropical Medicine
Year:
2009
Volume:
4
Issue:
1
Page No.
4 - 8
References
Akande, A.A. and T.M. Akande, 2006. Polio eradication in Nigeria: Controversies and way forward. Afr. J. Clin. Exp. Microbiol., 7: 175-181.
Centre for Disease Control (CDC), 2005. Progress toward poliomyelitis eradication Nigeria. MMWR., 54: 873-877.
Centre for Disease Control (CDC), 2005. Progress towards interruption of wild poliomyelitis transmission-world wide. MMWR., 54: 408-412.
Hennessey, K.A., A. Marx, R. Hafiz, H. Ashgar, S.C. Hadler, H. Jafari and R.W. Sutter, 2000. Widespread of paralytic poliomyelitis in Pakistan: A case control study to determine risk factors and implications for polio eradication. J. Infect. Dis., 182: 6-11.
Lernout, T. and V. Van Casteren, 2005. Surveillance a key strategy in the elimination of diseases-the case of polio and measles surveillance in Belgium. Arch. Public Health, 63: 171-184.
Marx, A., T.D. Glass and R.W. Sutter, 2002. Differential diagnoses of Acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol. Rev., 22: 298-316.
Ndiaye, S.M., L. Quick, O. Sanda and S. Niandou, 2003. The value of community participation in disease surveillance: A case study of Niger. Health Promot. Int., 18: 89-98.
Ngcobo, N.J., 2002. AFP surveillance in South African. Disease Surveillance Bulletin, pp: 4-12.
Olawoye, R.O., A.O. Awoyemi, T.M. Akande and G.K. Oshagbemi, 2000. A review of polio eradication strategies in Kwara State, Nigeria. Afr. J. Clin. Exp. Microbiol., 1: 85-92.
Oostvogel, P.M., J.K. van Wijigaarden and H.G. van Der Avoort , 1994. Poliomyelitis in an unvaccinated community in Netherlands. Lancet, 344: 665-670.
Prevots, D.R., M.L. Ciofi Degli Atti, A. Sallabanda, E. Diamante and R.B. Aylward
et al., 1998. Outbreak of poliomyelitis in Albania: High attack rates among adults and apparents interruption of transmission following Nation-wide mass vaccination. Clin. Infect. Dis., 26: 419-425.
Wyath, H.V., 1995. Poliomyelitis in Indian adult. Vat. Med. J. Ind., 8: 133-135.